‘Practitioners should consider in a careful and compassionate manner whether transplantation is an authentic option for every elderly end-stage renal disease candidate,’ they wrote. ‘Each transplant program must carefully consider the most cost-effective and clinically rational manner in which their elderly applicants are evaluated and maintained while on the waiting list.’.. Usage of kidney transplantation raises for elderly patients Elderly patients with kidney failure get kidney transplants more regularly than they did a decade ago, according to a study appearing in an upcoming problem of the Clinical Journal of the American Society of Nephrology .But opponents cited a bunch of issues about the drug. Among the issues: symptoms of extreme exhaustion and the potential for accidental injuries, along with questions about the medication’s effectiveness. An FDA advisory panel voted 18 to 6 in June to recommend the drug’s approval, however the endorsement was somewhat muted. The committee known as the drug’s benefits moderate or marginal, and the panel associates who voted yes said full FDA approval should include conditions. One of flibanserin’s detractors is psychotherapist Keesha Ewers, chief and founder medical officer of the Functional Sexology Institute, who also contends the drug hasn’t been been shown to be very effective.